Supplementary
: Metformin regulates miRNAs expression in GSCs. GSCs were treated with control (DMEM), 1 mM or 10 mM metformin for 3 days and the expression of miR-124, miR-137 and Let-7 was determined using qPCR. The results are representative of three different experiments that gave similar results. ****p < 0.0001.
Supplementary Figure S3: Phenformin inhibits tumor growth and prolongs the survival of mice bearing GSCderived xenografts. (A)
Representative BLI images from control (PBS, i.p., n = 10) and phenformin treated mice (i.p. 50 mg/kg/day, n = 10). BLI was performed 2 weeks following 2 weeks of phenformin treatment. (B) Average BLI values for each group were analyzed, the effect of phenformin on tumor growth was analyzed by comprising BLI change before and after treatment. BLI fold change = photon flux from mice at 8 weeks after implantation of tumors (i.e. 2 weeks after treatment)/photon flux of mice at 2 weeks after implantation of tumors. (C) Kaplan-Meier survival curves of mice treated with vehicle (PBS) or phenformin (100 mg/kg/day) administered via oral gavage. (D) Kaplan-Meier survival curves of mice treated with vehicle (PBS), metformin (400 mg/kg/day) or phenformin (100 mg/kg/day) administered via oral gavage.
